Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates

A novel coronavirus (SARS-CoV-2) identified in Wuhan state of China in 2019 is the causative agent of deadly disease COVID-19. It has spread across the globe (more than 210 countries) within a short period. Coronaviruses pose serious health threats to both humans and animals. A recent publication re...

Descripción completa

Detalles Bibliográficos
Autores principales: Alazmi, Meshari, Motwalli, Olaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657070/
https://www.ncbi.nlm.nih.gov/pubmed/33175236
http://dx.doi.org/10.1007/s00894-020-04599-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657070/
https://www.ncbi.nlm.nih.gov/pubmed/33175236
http://dx.doi.org/10.1007/s00894-020-04599-8

Ejemplares similares